A rare gastrointestinal cancer is rising sharply among Gen X and Millennials, prompting experts to call for more research.

Experts worry about the uptick in cases as more Gen Xers and millennials are being diagnosed with a variety of ...

While many Britons are starting to know the warning signs for bowel cancer, a new study has revealed a shocking rise in ...

Marwan G. Fakih, MD, discusses topics in metastatic colorectal cancer from the Case-Based Roundtable meeting he moderated.

Appendix cancer is a condition that, until recently, was so rare that most people never gave it a second thought.

Appendix cancer cases are rising among millennials and Gen X, often mimicking diverticulitis symptoms. Early diagnosis ...

Niraparib maintenance has a tolerable safety profile in patients with ovarian cancer, with hematologic toxicities being “the primary concern,” according to researchers. They evaluated the safety of ...

Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors and were among the first solid tumor types for which such a novel treatment (in this case imatinib) became available. The ...

Apollo Cancer Centre, Chennai introduces robotic pancreatic surgery program for complex surgeries, ensuring precision, ...

The FDA has approved a revised label for Merck’s immunotherapy drug Keytruda, limiting its use in some gastrointestinal cancer treatments to patients whose tumors express a minimum level of PD-L1 ...

Rates of appendiceal adenocarcinoma more than tripled among Americans born in 1980 compared with those born in 1945, a study ...